Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Immunome (IMNM) had its price target raised by Craig Hallum from $33.00 to $36.00. They now have a "buy" rating on the stock.
Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing [Yahoo! Finance]
Immunome (IMNM) had its price target lowered by Stephens from $33.00 to $30.00. They now have an "overweight" rating on the stock.
Immunome Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]